• 80 Citations
  • 5 h-Index
20092020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 80 Citations
  • 5 h-Index
  • 19 Article
  • 2 Letter
  • 1 Comment/debate
2020
Open Access
Open Access
1 Citation (Scopus)
2019

Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment

Lee, S. R., Choi, H., Lee, B. H., Kang, K. W., Yu, E. S., Kim, D. S., Park, Y., Choi, C. W., Kim, B. S. & Sung, H. J., 2019 Nov, In : Korean Journal of Internal Medicine. 34, 6, p. 1333-1346 14 p.

Research output: Contribution to journalArticle

Open Access

Single-dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma

Park, Y., Kim, D. S., Jeon, M. J., Lee, B. H., Yu, E. S., Kang, K. W., Lee, S. R., Sung, H. J., Nam, M-H., Yoon, S-Y., Choi, C. W., Kang, E. S., Cho, D., Kim, K., Kim, B. S., Kim, D. W. & Kim, S. J., 2019 Jan 1, In : Journal of Clinical Apheresis.

Research output: Contribution to journalArticle

2018

A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score

Yhim, H. Y., Park, Y., Han, Y. H., Kim, S., Kang, S. R., Moon, J. H., Jeong, J. H., Shin, H. J., Kim, K., Choi, Y. S., Kim, K., Kim, M. K., Kong, E., Kim, D. S., Eo, J. S., Lee, J. H., Kang, D. Y., Lee, W. S., Lee, S. M., Do, Y. R. & 6 others, Ham, J. S., Kim, S. J., Kim, W. S., Choi, J. Y., Yang, D. H. & Kwak, J. Y., 2018 Dec 1, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 13, p. 2274-2284 11 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score (European Journal of Nuclear Medicine and Molecular Imaging, (2018), 45, 13, (2274-2284), 10.1007/s00259-018-4093-1)

Yhim, H. Y., Park, Y., Han, Y. H., Kim, S., Kang, S. R., Moon, J. H., Jeong, J. H., Shin, H. J., Kim, K., Choi, Y. S., Kim, K., Kim, M. K., Kong, E., Kim, D. S., Eo, J. S., Lee, J. H., Kang, D. Y., Lee, W. S., Lee, S. M., Do, Y. R. & 6 others, Ham, J. S., Kim, S. J., Kim, W. S., Choi, J. Y., Yang, D. H. & Kwak, J. Y., 2018 Dec 1, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 13, p. 2482-2483 2 p.

Research output: Contribution to journalComment/debate

2 Citations (Scopus)

Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party

Jung, S. H., Lee, S. R., Yang, D. H., Lee, S., Yoon, J. H., Lee, H., Bang, S. M., Koh, Y., Park, S., Kim, D. S., Yhim, H. Y., Kim, S. H., Lee, J. H., Sohn, S. K., Song, I. C., Lee, H. G., Cheong, J. W., Choi, Y. & Shin, H. J., 2018 Jan 1, (Accepted/In press) In : Annals of Hematology.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma

Kang, K. W., Lee, S. R., Kim, D. S., Yu, E. S., Sung, H. J., Kim, S. J., Choi, C. W., Park, Y. & Kim, B. S., 2018 Feb 1, In : PLoS One. 13, 2, e0192656.

Research output: Contribution to journalArticle

1 Citation (Scopus)

The potential of exosomes derived from chronic myelogenous leukaemia cells as a biomarker

Kang, K. W., Jung, J. H., Hur, W., Park, J., Shin, H., Choi, B., Jeong, H., Kim, D. S., Yu, E. S., Lee, S. R., Sung, H. J., Kim, S. J., Choi, C. W., Kim, H. K., Hong, S., Park, J. H., Choi, Y., Park, Y. & Kim, B. S., 2018 Jul 1, In : Anticancer Research. 38, 7, p. 3935-3942 8 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2017

BCR-ABL translocation as a favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors

The Korean Adult ALL Working Party & Korean Society of Hematology, 2017 Apr 30, In : Haematologica. 102, 5, p. e187-e190

Research output: Contribution to journalLetter

3 Citations (Scopus)
2 Citations (Scopus)
8 Citations (Scopus)
2016

Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells

Kim, D. S., Na, Y. J., Kang, M. H., Yoon, S-Y. & Choi, C. W., 2016 Mar 1, In : Korean Journal of Internal Medicine. 31, 2, p. 357-366 10 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2015
6 Citations (Scopus)
3 Citations (Scopus)
2013
5 Citations (Scopus)
2012
7 Citations (Scopus)
2010

The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease

Park, Y., Kim, D. S., Park, S. J., Seo, H. Y., Lee, S. R., Sung, H. J., Park, K. H., Choi, I. K., Kim, S. J., Oh, S. C., Seo, J. H., Choi, C. W., Kim, B. S., Shin, S. W., Kim, Y. H. & Kim, J. S., 2010 Mar 1, In : Leukemia Research. 34, 3, p. 294-300 7 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)
2009
15 Citations (Scopus)